These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 35437630)

  • 1. Solid dispersion technology as a formulation strategy for the fabrication of modified release dosage forms: A comprehensive review.
    Patel K; Shah S; Patel J
    Daru; 2022 Jun; 30(1):165-189. PubMed ID: 35437630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Delayed Release Oral Formulation Comprising Esomeprazole Spray Dried Dispersion Utilizing Design of Experiment As An Optimization Strategy.
    Patel K; Patel J; Shah S
    AAPS PharmSciTech; 2023 Sep; 24(7):186. PubMed ID: 37700215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an Amorphous Solid Dispersion Formulation for Mitigating Mechanical Instability of Crystalline Form and Improving Bioavailability for Early Phase Clinical Studies.
    Chiang CW; Lubach JW; Chen T; Chin S; Ly J; Zhang W; Hou HH; Nagapudi K
    Mol Pharm; 2023 May; 20(5):2452-2464. PubMed ID: 37010134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
    Chella N; Tadikonda R
    Drug Dev Ind Pharm; 2015 Jun; 41(6):888-97. PubMed ID: 24796274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on Strategies Using Swellable Polymers in Solid Dispersions for Controlled Drug Release.
    Tran TTD; Tran PHL
    Curr Pharm Des; 2017; 23(11):1639-1648. PubMed ID: 27774901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption.
    Guan J; Jin L; Liu Q; Xu H; Wu H; Zhang X; Mao S
    Eur J Pharm Sci; 2019 Nov; 139():105043. PubMed ID: 31415903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosage form designs for the controlled drug release of solid dispersions.
    Tran PHL; Tran TTD
    Int J Pharm; 2020 May; 581():119274. PubMed ID: 32234566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution enhancement of atorvastatin calcium by co-grinding technique.
    Prabhu P; Patravale V
    Drug Deliv Transl Res; 2016 Aug; 6(4):380-91. PubMed ID: 26712124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the potential of solid dispersion for improving solubility, dissolution & bioavailability of herbal extracts, enriched fractions, and bioactives.
    Mohapatra D; Agrawal AK; Sahu AN
    J Microencapsul; 2021; 38(7-8):594-612. PubMed ID: 34338596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in the Surfactant and Controlled Release Polymer-based Solid Dispersion.
    Gupta A; Paudwal G; Dolkar R; Lewis S; Gupta PN
    Curr Pharm Des; 2022; 28(20):1643-1659. PubMed ID: 35209818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patents.
    Alshehri S; Imam SS; Hussain A; Altamimi MA; Alruwaili NK; Alotaibi F; Alanazi A; Shakeel F
    Drug Deliv; 2020 Nov; 27(1):1625-1643. PubMed ID: 33207947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Solid State NMR Investigation for Molecular States of Specialized Formulation to Improve the Water Solubility of Poorly Water-soluble Drugs].
    Higashi K
    Yakugaku Zasshi; 2021; 141(9):1063-1069. PubMed ID: 34471007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral bioavailability enhancement of β-lapachone, a poorly soluble fast crystallizer, by cocrystal, amorphous solid dispersion, and crystalline solid dispersion.
    Liu C; Liu Z; Chen Y; Chen Z; Chen H; Pui Y; Qian F
    Eur J Pharm Biopharm; 2018 Mar; 124():73-81. PubMed ID: 29305142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid dispersion technology as a strategy to improve the bioavailability of poorly soluble drugs.
    Cid AG; Simonazzi A; Palma SD; Bermúdez JM
    Ther Deliv; 2019 Jun; 10(6):363-382. PubMed ID: 31094298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative assessment of solubility enhancement of itroconazole by solid dispersion and co-crystallization technique: Investigation of simultaneous effect of media composition on drug dissolution.
    Rajbhar K; Karodadeo GR; Kumar V; Barethiya V; Lahane A; Kale S; Thakre V; Dixit G; Kohale N; Hiradeve S; Rarokar NR
    Ann Pharm Fr; 2023 Sep; 81(5):843-855. PubMed ID: 37182590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid Dispersion: A Mechanistic and Realistic Approach on Antihypertensive Drug as a Drug Carrier System.
    Swarup P; Agrawal GP
    Assay Drug Dev Technol; 2021 Jul; 19(5):282-289. PubMed ID: 34015231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
    Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels.
    Schver GCRM; Lee PI
    Mol Pharm; 2018 May; 15(5):2017-2026. PubMed ID: 29601723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulation of Solid Dispersion in Solid Lipid Particles for Dissolution Enhancement of Poorly Water-Soluble Drug.
    My Tran KT; Vo TV; Lee BJ; Duan W; Ha-Lien Tran P; Truong-Dinh Tran T
    Curr Drug Deliv; 2018; 15(4):576-584. PubMed ID: 28595530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.